Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- Check2 days agoChange DetectedThe page revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a minor site release without changing the displayed study details.SummaryDifference0.1%

- Check9 days agoChange DetectedPage revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 added. Revision: v3.4.3 removed.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated to v3.4.2. Previous notices, including the government funding lapse notice and Revision: v3.4.1, were removed.SummaryDifference0.5%

- Check81 days agoChange DetectedAdded a government funding lapse notice at the top of the page and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.